JD Health International, Inc. (HK:6618)
:6618
6618 Stock Chart & Stats
HK$60.30
HK$0.45(1.61%)
At close: 4:00 PM EST
HK$60.30
HK$0.45(1.61%)
Day’s Range― - ―
52-Week RangeHK$27.15 - HK$71.70
Previous CloseN/A
Volume5.25M
Average Volume (3M)7.60M
Market Cap
HK$166.96B
Enterprise ValueHK$113.91B
Total Cash (Recent Filing)HK$47.00B
Total Debt (Recent Filing)HK$636.29M
Price to Earnings (P/E)30.1
Beta1.45
Next Earnings
Aug 13, 2026EPS Estimate
1.32Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.07
Shares Outstanding3,210,775,100
10 Day Avg. Volume6,883,323
30 Day Avg. Volume7,596,953
Financial Highlights & Ratios
PEG Ratio1.20
Price to Book (P/B)2.62
Price to Sales (P/S)2.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$74.91Price Target Upside24.23% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering11
EPS Forecast (FY)1.85
Revenue Forecast (FY)HK$87.28B
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetExceptionally low leverage and rising equity provide durable financial flexibility. This conservatism supports multi-year investments (AI, supply chain, pharmacies), reduces refinancing risk in stress, and gives optionality to fund growth or cushion cyclical healthcare headwinds without eroding core operations.
Sustained Revenue And Profit ExpansionConsistent double-digit top-line growth and outsized profit improvement signal scalable economics and improving operating leverage. Over 20% YoY growth across quarters and margin expansion indicate the core e-commerce and services businesses are maturing into repeatable, higher‑quality cash-generating operations.
Integrated AI, Product Launches And Omnichannel EcosystemHigh engagement AI tools, a launch platform for innovative drugs and an omnichannel supply chain create structural differentiation. These assets deepen provider and vendor partnerships, raise barriers to entry for pure-play competitors, and enable cross-selling and lifetime-value gains over multiple years.
Bears Say
Free Cash Flow ResetA meaningful decline in free cash flow reduces near-term financial flexibility and heightens reliance on operating performance or external funding for investments. If higher capex or working-capital needs persist, the company may face constrained ability to sustain discretionary spend or accelerate offline rollouts.
High Direct-sales ConcentrationHeavy revenue reliance on direct-sales channels concentrates exposure to supplier, product and category risk. Structural shifts—pricing pressure, supplier terms, or regulatory change—could disproportionately impact margins and growth, making diversification of service and channel mixes a material multi‑quarter priority.
AI Monetization Uncertainty And Rising Operating CostsWhile AI engagement is strong, unclear commercialization timelines plus materially higher S&M and fulfillment costs can compress margins if revenue conversion lags. Sustained investment without clear monetization ramps increases execution risk and could pressure returns during the commercialization window.
JD Health International, Inc. News
6618 FAQ
What was JD Health International, Inc.’s price range in the past 12 months?
JD Health International, Inc. lowest stock price was HK$27.15 and its highest was HK$71.70 in the past 12 months.
What is JD Health International, Inc.’s market cap?
JD Health International, Inc.’s market cap is HK$166.96B.
When is JD Health International, Inc.’s upcoming earnings report date?
JD Health International, Inc.’s upcoming earnings report date is Aug 13, 2026 which is in 126 days.
How were JD Health International, Inc.’s earnings last quarter?
JD Health International, Inc. released its earnings results on Mar 05, 2026. The company reported HK$1.071 earnings per share for the quarter, beating the consensus estimate of HK$0.745 by HK$0.327.
Is JD Health International, Inc. overvalued?
According to Wall Street analysts JD Health International, Inc.’s price is currently Undervalued.
Does JD Health International, Inc. pay dividends?
JD Health International, Inc. does not currently pay dividends.
What is JD Health International, Inc.’s EPS estimate?
JD Health International, Inc.’s EPS estimate is 1.32.
How many shares outstanding does JD Health International, Inc. have?
JD Health International, Inc. has 3,210,775,100 shares outstanding.
What happened to JD Health International, Inc.’s price movement after its last earnings report?
JD Health International, Inc. reported an EPS of HK$1.071 in its last earnings report, beating expectations of HK$0.745. Following the earnings report the stock price went down -6.219%.
Which hedge fund is a major shareholder of JD Health International, Inc.?
Currently, no hedge funds are holding shares in HK:6618
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
JD Health International, Inc. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
130.47%
12-Months-Change
Fundamentals
Return on Equity
9.03%
Trailing 12-Months
Asset Growth
19.80%
Trailing 12-Months
Company Description
JD Health International, Inc.
JD Health International Inc., an investment holding company, operates an online healthcare platform in the People's Republic of China. It offers pharmaceutical and healthcare products, including OTC drugs, prescription drugs, and medical devices and supplies, as well as health supplements and tonics through direct selling and an online retail pharmacy network. The company also provides online healthcare services, online consultation, hospital or doctor referral, health check-ups, genetic testing, and beauty care services; health management and intelligent healthcare solutions, as well as technical and advertising services. In addition, it offers access to medical checkups, medical aesthetics, vaccination appointments, dental care services, and nucleic acid testing tests. The company was incorporated in 2018 and is headquartered in Beijing, the People's Republic of China. JD Health International Inc. is a subsidiary of JD Jiankang Limited.
6618 Stock 12 Month Forecast
Average Price Target
HK$74.91
▲(24.23% Upside)
Technical Analysis
Rici Healthcare Holdings Ltd.
―
Jinxin Fertility Group Ltd.
―
Gushengtang Holdings Limited
―
Guangdong Kanghua Healthcare Co., Ltd. Class H
―
Hygeia Healthcare Holdings Co., Ltd.
―
Options Prices
Currently, No data available
---